Novel synthesis and pharmacological evaluation as alpha2-adrenoceptor ligands of O-phenylisouronium salts

Bioorg Med Chem. 2008 Sep 1;16(17):8210-7. doi: 10.1016/j.bmc.2008.07.033. Epub 2008 Jul 20.

Abstract

The synthesis of nine new mono- and bis-O-phenylisouronium compounds (2, 6b-10b and 12b-14b) and their Boc-protected isourea precursors (2a, 6a-10a and 12a-14a) is described. The carbodiimide 4, which was formed, had been suggested as the reactive intermediate species and driving force of the reaction. All final substrates were tested as potential alpha(2)-ARs ligands in human brain tissue by means of radioligand binding experiments and were compared to the potential antidepressant 1, as well as other related guanidine containing derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists*
  • Antidepressive Agents / chemical synthesis*
  • Antidepressive Agents / chemistry
  • Antidepressive Agents / pharmacology
  • Brain / drug effects
  • Brain / metabolism*
  • Crystallography, X-Ray
  • Drug Evaluation, Preclinical
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Structure
  • Salts / chemical synthesis
  • Salts / chemistry
  • Salts / pharmacology
  • Stereoisomerism
  • Structure-Activity Relationship
  • Sulfides / chemical synthesis*
  • Sulfides / chemistry
  • Sulfides / pharmacology
  • Urea / analogs & derivatives*
  • Urea / chemical synthesis*
  • Urea / chemistry
  • Urea / pharmacology*

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Antidepressive Agents
  • Ligands
  • Salts
  • Sulfides
  • Urea